Phendimetrazine: Side Effects, Uses & Monitoring
Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index
- Data source
- FDA labeling via NIH DailyMed (label 05bb0569…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follow: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. BODY MASS INDEX (BMI), kg/m 2 Height (feet, inches) | Weight | 5’0” | 5’3” | 5’6” | 5’9” | 6’0” | 6’3” | (pounds) | | | | | | | 140 | 27 | 25 | 23 | 21 | 19 | 18 | 150 | 29 | 27 | 24 | 22 | 20 | 19 | 160 | 31 | 28 | 26 | 24 | 22 | 20 | 170 | 33 | 30 | 28 | 25 | 23 | 21 | 180 | 35 | 32 | 29 | 27 | 25 | 23 | 190 | 37 | 34 | 31 | 28 | 26 | 24 | 200 | 39 | 36 | 32 | 30 | 27 | 25 | 210 | 41 | 37 | 34 | 31 | 29 | 26 | 220 | 43 | 39 | 36 | 33 | 30 | 28 | 230 | 45 | 41 | 37 | 34 | 31 | 29 | 240 | 47 | 43 | 39 | 36 | 33 | 30 | 250 | 49 | 44 | 40 | 37 | 34 | 31 | Phendimetraz…
Conditions associated with Phendimetrazine in labeling
Frequently Asked Questions
What is Phendimetrazine used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Phendimetrazine?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Phendimetrazine require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Phendimetrazine.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.